Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2022 Filed Feb 16, 2022 00:56 UTC |
Nayak Abhay UExecutive Vice President
|
Exercise / conversionCommon Stock | 289 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000102 · wf-form4_164497296083623.xml · nonDerivative · entry 1 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:55 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionPerformance Award Unit · Derivative | 10,519.5758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000100 · wf-form4_164497289660078.xml · derivative · entry 6 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,519.5758 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:55 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,050.4942 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000100 · wf-form4_164497289660078.xml · derivative · entry 5 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,890.6871 Underlying: Common Stock · 3,050.4942 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,050.4942 RSUs vested on February 12, 2022; 1,842.4714 RSUs will vest on February 11, 2023; 1,682.2157 RSUs will vest on February 10, 2024; and 1,366 RSUs will vest on February 8, 2025. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,050.4942 RSUs vested on February 12, 2022; 1,842.4714 RSUs will vest on February 11, 2023; 1,682.2157 RSUs will vest on February 10, 2024; and 1,366 RSUs will vest on February 8, 2025. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,050.4942 RSUs vested on February 12, 2022; 1,842.4714 RSUs will vest on February 11, 2023; 1,682.2157 RSUs will vest on February 10, 2024; and 1,366 RSUs will vest on February 8, 2025. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:55 UTC |
Lagano RoxanneExecutive Vice President
|
Tax withholdingCommon Stock | 4,446 | $198.87 | $884,176.02 |
DisclosureSEC source: 0001555280-22-000100 · wf-form4_164497289660078.xml · nonDerivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,752 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:55 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 10,519 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000100 · wf-form4_164497289660078.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:55 UTC |
Lagano RoxanneExecutive Vice President
|
Tax withholdingCommon Stock | 985 | $198.87 | $195,886.95 |
DisclosureSEC source: 0001555280-22-000100 · wf-form4_164497289660078.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,679 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:55 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 3,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000100 · wf-form4_164497289660078.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:54 UTC |
David GlennExecutive Vice President
|
Exercise / conversionPerformance Award Unit · Derivative | 21,543.6684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000098 · wf-form4_164497284675430.xml · derivative · entry 6 David Glenn · CIK 0001606256 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,543.6684 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F3 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F3 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F5 · derivative.exercise_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F5 · derivative.expiration_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:54 UTC |
David GlennExecutive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,247.4603 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000098 · wf-form4_164497284675430.xml · derivative · entry 5 David Glenn · CIK 0001606256 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,257.4985 Underlying: Common Stock · 6,247.4603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 6,247.4603 RSUs vested on February 12, 2022; 4,475.7293 RSUs will vest on February 11, 2023; 4,338.7692 RSUs will vest on February 10, 2024; and 3,443 RSUs will vest on February 8, 2025. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F4 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 6,247.4603 RSUs vested on February 12, 2022; 4,475.7293 RSUs will vest on February 11, 2023; 4,338.7692 RSUs will vest on February 10, 2024; and 3,443 RSUs will vest on February 8, 2025. F4 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 6,247.4603 RSUs vested on February 12, 2022; 4,475.7293 RSUs will vest on February 11, 2023; 4,338.7692 RSUs will vest on February 10, 2024; and 3,443 RSUs will vest on February 8, 2025. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:54 UTC |
David GlennExecutive Vice President
|
Tax withholdingCommon Stock | 9,869 | $198.87 | $1,962,648.03 |
DisclosureSEC source: 0001555280-22-000098 · wf-form4_164497284675430.xml · nonDerivative · entry 4 David Glenn · CIK 0001606256 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,572 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:54 UTC |
David GlennExecutive Vice President
|
Exercise / conversionCommon Stock | 21,543 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000098 · wf-form4_164497284675430.xml · nonDerivative · entry 3 David Glenn · CIK 0001606256 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F3 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:54 UTC |
David GlennExecutive Vice President
|
Tax withholdingCommon Stock | 2,336 | $198.87 | $464,560.32 |
DisclosureSEC source: 0001555280-22-000098 · wf-form4_164497284675430.xml · nonDerivative · entry 2 David Glenn · CIK 0001606256 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,898 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:54 UTC |
David GlennExecutive Vice President
|
Exercise / conversionCommon Stock | 6,247 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000098 · wf-form4_164497284675430.xml · nonDerivative · entry 1 David Glenn · CIK 0001606256 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · balance_after: This total reflects a transfer by the Reporting Person of 1,914 shares that was exempt from Section 16 that occurred in the second quarter of 2021. The Reporting Person no longer beneficially owns these transferred shares. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:53 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionPerformance Award Unit · Derivative | 13,025.884 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000096 · wf-form4_164497280611054.xml · derivative · entry 6 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,025.884 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:53 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,776.7536 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000096 · wf-form4_164497280611054.xml · derivative · entry 5 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,999.7063 Underlying: Common Stock · 3,776.7536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,776.7536 RSUs vested on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,073.3585 RSUs will vest on February 10, 2024; and 1,645 RSUs will vest on February 8, 2025. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,776.7536 RSUs vested on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,073.3585 RSUs will vest on February 10, 2024; and 1,645 RSUs will vest on February 8, 2025. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,776.7536 RSUs vested on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,073.3585 RSUs will vest on February 10, 2024; and 1,645 RSUs will vest on February 8, 2025. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:53 UTC |
Chen Heidi C.Executive Vice President
|
Tax withholdingCommon Stock | 5,678 | $198.87 | $1,129,183.86 |
DisclosureSEC source: 0001555280-22-000096 · wf-form4_164497280611054.xml · nonDerivative · entry 4 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:53 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 13,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000096 · wf-form4_164497280611054.xml · nonDerivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:53 UTC |
Chen Heidi C.Executive Vice President
|
Tax withholdingCommon Stock | 1,218 | $198.87 | $242,223.66 |
DisclosureSEC source: 0001555280-22-000096 · wf-form4_164497280611054.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,653 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:53 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 3,776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000096 · wf-form4_164497280611054.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:39 UTC |
MCCALLISTER MICHAEL BDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000059 · wf-form4_164453633049761.xml · derivative · entry 1 MCCALLISTER MICHAEL B · CIK 0001018657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 18:41 UTC |
Polzer Robert JExecutive Vice President
|
GrantStock Option · Derivative | 5,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000064 · wf-form4_164453646752522.xml · derivative · entry 3 Polzer Robert J · CIK 0001900620 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,412 Underlying: Common Stock · 5,455 shares Expires not disclosed F9 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F10 · derivative.exercise_price: 1,721 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,179 options granted February 11, 2020 at an exercise price of $144.03 per option; 1,057 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,455 options granted February 8, 2022 at an exercise price of $201.30 per option. F11 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F12 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 1,721 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,179 options granted February 11, 2020 at an exercise price of $144.03 per option; 1,057 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,455 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 18:41 UTC |
Polzer Robert JExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000064 · wf-form4_164453646752522.xml · derivative · entry 2 Polzer Robert J · CIK 0001900620 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,350.8331 Underlying: Common Stock · 1,385 shares Expires not disclosed F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject toearlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F8 · balance_after: The RSUs vest as follows: 435.3491 RSUs will vest on February 12, 2022; 280.1123 RSUs will vest on February 11, 2023; 250.3717 RSUs will vest on February 10, 2024; and 1,385 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 18:41 UTC |
Polzer Robert JExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 1,501.3438 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000064 · wf-form4_164453646752522.xml · derivative · entry 1 Polzer Robert J · CIK 0001900620 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,501.3438 Underlying: Common Stock · 1,501.3438 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 18:42 UTC |
Reed Willie MDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000065 · wf-form4_164453652192775.xml · derivative · entry 1 Reed Willie M · CIK 0001601695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:41 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 54,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000063 · wf-form4_164453644692465.xml · derivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,014 Underlying: Common Stock · 54,751 shares Expires not disclosed F9 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F10 · derivative.exercise_price: 15,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option. F11 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F12 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 15,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:41 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 13,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000063 · wf-form4_164453644692465.xml · derivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,903.3252 Underlying: Common Stock · 13,909 shares Expires not disclosed F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F8 · balance_after: The RSUs vest as follows: 5,230.2901 RSUs will vest on February 12, 2022; 13,303.8173 RSUs will vest on February 11, 2023; 14,460.2178 RSUs will vest on February 10, 2024; and 13,909 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:41 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantPerformance Award Unit · Derivative | 18,036.4652 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000063 · wf-form4_164453644692465.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,036.4652 Underlying: Common Stock · 18,036.4652 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 18:40 UTC |
Norden GregoryDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000061 · wf-form4_164453639646445.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:42 UTC |
SCULLY ROBERT WDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000067 · wf-form4_164453656286841.xml · derivative · entry 1 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Joseph WettenyChief Financial Officer
|
GrantStock Option · Derivative | 11,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000054 · wf-form4_164453620455599.xml · derivative · entry 2 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,243 Underlying: Common Stock · 11,243 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 11,243 options granted February 8, 2022 at an exercise price of $201.30 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 11,243 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Joseph WettenyChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 2,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000054 · wf-form4_164453620455599.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,332.3751 Underlying: Common Stock · 2,856 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 27,476.3751 RSUs will vest on June 30, 2024; and 2,856 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:34 UTC |
Bisaro PaulDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000049 · wf-form4_164453606281441.xml · derivative · entry 1 BISARO PAUL · CIK 0001237253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:40 UTC |
PARENT LOUISE MDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000062 · wf-form4_164453641957937.xml · derivative · entry 1 PARENT LOUISE M · CIK 0001209456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:35 UTC |
DAMELIO FRANK ADirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000051 · wf-form4_164453611536773.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 18:42 UTC |
Rhodes LindaDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000066 · wf-form4_164453654167809.xml · derivative · entry 1 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 18:37 UTC |
Sanjay KhoslaDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000055 · wf-form4_164453623346572.xml · derivative · entry 1 Sanjay Khosla · CIK 0001387531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:38 UTC |
Mamilli WafaaExecutive Vice President
|
GrantStock Option · Derivative | 5,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000058 · wf-form4_164453630558630.xml · derivative · entry 2 Mamilli Wafaa · CIK 0001800960 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,607 Underlying: Common Stock · 5,377 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 16,951 options granted February 11, 2020 at an exercise price of $144.03 per option; 6,279 options granted February 10, 2021 at an exercise price of $160.62 per option; 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 16,951 options granted February 11, 2020 at an exercise price of $144.03 per option; 6,279 options granted February 10, 2021 at an exercise price of $160.62 per option; 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:38 UTC |
Mamilli WafaaExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000058 · wf-form4_164453630558630.xml · derivative · entry 1 Mamilli Wafaa · CIK 0001800960 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,887.9833 Underlying: Common Stock · 1,366 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 4,035.8418 RSUs will vest on February 11, 2023; 1,486.1415 RSUs will vest on February 10, 2024; and 1,366 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:36 UTC |
Ferran Astorga JeannetteExecutive Vice President
|
GrantStock Option · Derivative | 1,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000053 · wf-form4_164453616716277.xml · derivative · entry 2 Ferran Astorga Jeannette · CIK 0001900614 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,057 Underlying: Common Stock · 1,828 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 1,304 options granted September 30, 2020 at an exercise price of $165.37 per option; 925 options granted February 10, 2021 at an exercise price of $160.62 per option; and 1,828 options granted February 8, 2022 at an exercise price of $201.30 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 1,304 options granted September 30, 2020 at an exercise price of $165.37 per option; 925 options granted February 10, 2021 at an exercise price of $160.62 per option; and 1,828 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:36 UTC |
Ferran Astorga JeannetteExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000053 · wf-form4_164453616716277.xml · derivative · entry 1 Ferran Astorga Jeannette · CIK 0001900614 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 986.7009 Underlying: Common Stock · 464 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject toearlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 304.5056 RSUs will vest on September 30, 2023; 218.1953 RSUs will vest on February 10, 2024; and 464 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Trawicki RomanExecutive Vice President
|
GrantStock Option · Derivative | 7,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000068 · wf-form4_164453658234517.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,941 Underlying: Common Stock · 7,332 shares Expires not disclosed F9 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F10 · derivative.exercise_price: 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option. F11 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F12 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Trawicki RomanExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000068 · wf-form4_164453658234517.xml · derivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,821.2108 Underlying: Common Stock · 1,862 shares Expires not disclosed F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F8 · balance_after: The RSUs vest as follows: 3,486.8600 RSUs will vest on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,191.0030 RSUs will vest on February 10, 2024; and 1,862 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Trawicki RomanExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 12,022.9538 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000068 · wf-form4_164453658234517.xml · derivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,022.9538 Underlying: Common Stock · 12,022.9538 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:39 UTC |
Nayak Abhay UExecutive Vice President
|
GrantStock Option · Derivative | 2,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000060 · wf-form4_164453635817540.xml · derivative · entry 3 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,106 Underlying: Common Stock · 2,823 shares Expires not disclosed F9 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F10 · derivative.exercise_price: 1,147 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,658 options granted February 11, 2020 at an exercise price of $144.03 per option; 2,478 options granted February 10, 2021 at an exercise price of $160.62 per option; and 2,823 options granted February 8, 2022 at an exercise price of $201.30 per option. F11 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F12 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 1,147 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,658 options granted February 11, 2020 at an exercise price of $144.03 per option; 2,478 options granted February 10, 2021 at an exercise price of $160.62 per option; and 2,823 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:39 UTC |
Nayak Abhay UExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 717 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000060 · wf-form4_164453635817540.xml · derivative · entry 2 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987.487 Underlying: Common Stock · 717 shares Expires not disclosed F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F8 · balance_after: The RSUs vest as follows: 289.8937 RSUs will vest on February 12, 2022; 394.3819 RSUs will vest on February 11, 2023; 586.2114 RSUs will vest on February 10, 2024; and 717 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:39 UTC |
Nayak Abhay UExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 1,000.8958 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000060 · wf-form4_164453635817540.xml · derivative · entry 1 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000.8958 Underlying: Common Stock · 1,000.8958 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:38 UTC |
Leatherberry Antoinette ReneeDirector
|
GrantRestricted Stock Unit · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000057 · wf-form4_164453628211559.xml · derivative · entry 1 Leatherberry Antoinette Renee · CIK 0001834624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,087.0731 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 1,456.1904 RSUs will vest on December 8, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lagano RoxanneExecutive Vice President
|
GrantStock Option · Derivative | 5,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000056 · wf-form4_164453626048509.xml · derivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,237 Underlying: Common Stock · 5,377 shares Expires not disclosed F9 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F10 · derivative.exercise_price: 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. F11 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F12 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lagano RoxanneExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000056 · wf-form4_164453626048509.xml · derivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,941.1813 Underlying: Common Stock · 1,366 shares Expires not disclosed F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F8 · balance_after: The RSUs vest as follows: 3,050.4942 RSUs will vest on February 12, 2022; 1,842.4714 RSUs will vest on February 11, 2023; 1,682.2157 RSUs will vest on February 10, 2024; and 1,366 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 10,519.5758 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000056 · wf-form4_164453626048509.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,519.5758 Underlying: Common Stock · 10,519.5758 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.